When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Cefepime - Wikipedia

   en.wikipedia.org/wiki/Cefepime

   Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both types of organism than third-generation agents. A 2007 meta-analysis suggested when data of trials were combined, mortality was increased in people treated with cefepime compared with other β-lactam antibiotics. [1]

3. Management of depression - Wikipedia

   en.wikipedia.org/wiki/Management_of_depression

   Three subsequent 2014 systematic reviews that included the Cochrane review in their analysis concluded with similar findings: one indicated that physical exercise is effective as an adjunct treatment with antidepressant medication; [170] the other two indicated that physical exercise has marked antidepressant effects and recommended the ...

4. Depressant - Wikipedia

   en.wikipedia.org/wiki/Depressant

   When depressants are used, effects often include ataxia, anxiolysis, pain relief, sedation or somnolence, cognitive or memory impairment, as well as, in some instances, euphoria, dissociation, muscle relaxation, lowered blood pressure or heart rate, respiratory depression, and anticonvulsant effects.

5. The first pill for postpartum depression is finally getting ...

   www.aol.com/first-pill-postpartum-depression...

   The pills are taken daily for two weeks, in the evening with a fatty meal. The medication isn’t ideal for mild postpartum depression, or the “baby blues,” doctors said.

6. First-ever pill for postpartum depression is up for FDA ... - AOL

   www.aol.com/news/first-ever-pill-postpartum...

   The FDA is about to decide whether to approve the first-ever pill for postpartum depression. The medication could also get approved for clinical depression. ... The medication could also get ...

7. US FDA approves Biogen-Sage Therapeutics pill for ... - AOL

   www.aol.com/news/us-fda-approves-biogen-sage...

   The companies had sought the FDA's approval for the drug, Zurzuvae, to treat major depressive disorder (MDD), or clinical depression, as well as postpartum depression, which affect millions of people.